AVG Stock Overview
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Avantor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$13.10 |
| 52 Week High | US$25.20 |
| 52 Week Low | US$12.50 |
| Beta | 1.24 |
| 1 Month Change | -9.03% |
| 3 Month Change | -38.79% |
| 1 Year Change | -43.04% |
| 3 Year Change | -54.98% |
| 5 Year Change | 5.65% |
| Change since IPO | -8.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| AVG | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -2.2% | 5.0% | 2.4% |
| 1Y | -43.0% | -25.5% | 2.0% |
Return vs Industry: AVG underperformed the German Life Sciences industry which returned -25.5% over the past year.
Return vs Market: AVG underperformed the German Market which returned 2% over the past year.
Price Volatility
| AVG volatility | |
|---|---|
| AVG Average Weekly Movement | 9.4% |
| Life Sciences Industry Average Movement | 7.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 12.3% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: AVG's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: AVG's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 13,500 | Michael Stubblefield | www.avantorsciences.com |
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.
Avantor, Inc. Fundamentals Summary
| AVG fundamental statistics | |
|---|---|
| Market cap | €9.12b |
| Earnings (TTM) | €626.48m |
| Revenue (TTM) | €5.97b |
14.9x
P/E Ratio1.6x
P/S RatioIs AVG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVG income statement (TTM) | |
|---|---|
| Revenue | US$6.78b |
| Cost of Revenue | US$4.50b |
| Gross Profit | US$2.28b |
| Other Expenses | US$1.57b |
| Earnings | US$711.50m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 25, 2025
| Earnings per share (EPS) | 1.04 |
| Gross Margin | 33.60% |
| Net Profit Margin | 10.49% |
| Debt/Equity Ratio | 67.8% |
How did AVG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 02:25 |
| End of Day Share Price | 2025/04/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avantor, Inc. is covered by 31 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Ishan Majumdar | Baptista Research |
| Luke Sergott | Barclays |